Page 4 - Highly Selective News Today

13.06.2022 - Leuven, BELGIUM, Boston, MA, US – JUNE 13, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today ...

Investegate announcements from Oxurion NV, Oxurion Announces Two Presentations at The Macula Society 45th Annual Meeting

Investegate announcements from Oxurion NV, Oxurion Announces Two Upcoming Presentations at The Macula Society 45th Annual Meeting

Leuven, BELGIUM, Boston, MA, US - JUNE 3, 2022 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies,

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Leuven, BELGIUM, Boston, MA, US – JUNE 3, 2022 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the first acute myeloid leukemia (AML) patient has enrolled in the fifth dose level (22.

Investegate announcements from RTW Venture Fund Ltd, New Investment in Third Harmonic Bio

Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid ...

/PRNewswire/ -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will...